Q2 2020 Holdings
Filed 2020-08-14 | 45 holdings | $912.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $258.8M | 1,750,000 | 28.4% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $228.2M | 1,850,000 | 25.0% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $218.5M | 970,000 | 23.9% |
| Adaptimmune Therapeutics PLC(ADAPY) | Sponsored ADR | 00653A107 | $100.1M | 10,000,000 | 11.0% |
| Allogene Therapeutics Inc(ALLO) | Common | 019770106 | $48.3M | 1,128,594 | 5.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | Common | 05156V102 | $27.1M | 1,670,000 | 3.0% |
| Black Diamond Therapeutics Inc(BDTX) | Common | 09203E105 | $22.1M | 525,000 | 2.4% |
| Cardiff Oncology Inc(CRDF) | Common | 14147L108 | $5.0M | 1,000,000 | 0.5% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $930.3K | 26,250,000 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $489.4K | 4,286,765 | 0.1% |
| Horizon Therapeutics PLC | Common | G46188101 | $333.5K | 6,000,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $284.4K | 10,361,039 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $268.6K | 1,675,000 | 0.0% |
| Myokardia Inc | Common | 62857M105 | $181.6K | 1,880,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $165.9K | 11,000,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | Common | 00773U108 | $158.4K | 7,585,000 | 0.0% |
| Mersana Therapeutics Inc | Common | 59045L106 | $152.1K | 6,500,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | Common | 48576U106 | $132.6K | 7,000,000 | 0.0% |
| Constellation Pharmaceuticals Inc(CNST) | Common | 210373106 | $120.2K | 4,000,000 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | Common | 24344T101 | $111.1K | 1,860,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | Common | 00434H108 | $99.1K | 1,040,000 | 0.0% |
| Uniqure NV(QURE) | Common | N90064101 | $67.6K | 1,500,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | Common | 75955J402 | $63.8K | 1,425,000 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $60.8K | 2,250,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | Common | 040047607 | $59.8K | 950,000 | 0.0% |
| Athenex Inc(ATNXEUR) | Common | 04685N103 | $53.0K | 3,850,000 | 0.0% |
| CUE Biopharma Inc(CUE) | Common | 22978P106 | $45.8K | 1,870,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $39.6K | 350,000 | 0.0% |
| Trillium Therapeutics Inc | Common | 89620X506 | $38.4K | 4,750,000 | 0.0% |
| Avadel Pharmaceuticals PLC | Sponsored ADR | 05337M104 | $36.9K | 4,565,655 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | Common | 46583P102 | $36.2K | 7,100,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $35.1K | 2,800,000 | 0.0% |
| Marinus Pharmaceuticals Inc | Common | 56854Q101 | $30.4K | 11,960,000 | 0.0% |
| Retrophin Inc | Common | 761299106 | $21.4K | 1,050,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $18.3K | 5,250,000 | 0.0% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $17.1K | 1,050,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | Common | 05370A108 | $16.5K | 585,000 | 0.0% |
| Tricida Inc(1T7) | Common | 89610F101 | $16.5K | 600,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | Common | 69366J200 | $16.5K | 324,750 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $13.9K | 1,670,000 | 0.0% |
| Amarin Corp PLC | Sponsored ADR | 023111206 | $13.8K | 2,000,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | Common | 76155X100 | $9.6K | 304,000 | 0.0% |
| Biodelivery Sciences Intl(BDSIUSD) | Common | 09060J106 | $8.9K | 2,034,900 | 0.0% |
| Alimera Sciences Inc | Common | 016259202 | $2.6K | 415,999 | 0.0% |
| Adaptimmune Therapeutics PLC(ADAPY)Call | Sponsored ADR | 00653A107 | $70 | 200,000 | 0.0% |